Subcontractors: Pharma & Beauty Group and Cetes Cosmetics join forces

Pharma & Beauty Group, a French specialist in the manufacture and filling of cosmetic and pharmaceutical products, and Cetes Cosmetics, the manufacturing arm of the Oriflame Group, will collaborate in a joint venture thus creating a new global player in the contract-manufacturing of cosmetic products.
The two companies have plans to create a joint venture under the name Pharma & Beauty International (PBI), with Cetes Cosmetics as a minor shareholder
Thanks to the complementarity of their two production networks and of their customer portfolios, the two companies intend to position PBI as a new global cosmetic subcontractor in order to meet the increasingly diverse needs of beauty brands around the world.
Created in 2012 by Laurent Dodet and Jean-Marie Total, France’s Pharma & Beauty Group operates four factories in France and specializes in the manufacture and filling of cosmetic (skincare, make-up, perfume, hygiene) and pharmaceutical products (medical devices, pharmaceuticals) and dietary supplements. Pharma & Beauty Group has a strong position as a contract manufacturer in France. For its part, Cetes Cosmetics is the manufacturing arm of Swedish cosmetics group Oriflame. Established in 2017 with headquarters in Schaffhausen, Switzerland, Cetes Cosmeticshas six plants in four countries (Poland, Russia, India and China). The company manufactures cosmetic products for both Oriflame and for external third-party customers.
PBI will be incorporated in France with headquarters in Paris and will be headed by Laurent Dodet as CEO.

“With PBI we will bring together the best from both partners; global footprint, wide range of technologies, breakthrough innovations, high-quality factories and a dynamic experienced management. PBI will be able to offer clients flexible production solutions in the combined 10 factories of both joint venture partners,” said Laurent Dodet in a release.
2026-09-03
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Vertex Buys Crinetics for $10 Billion: Rare Disease M&A Is Back
-
U.S. Includes Lithium in National Defense Stockpile for First Time, Plans to Purchase 16,200 Tons Over Five Years
-
COIM Group Expands Alkyd and Acrylic Resin Production Capacity in the Netherlands
-
Canada’s Acynonapyr Review Offers More Than a New Mite Product
-
West Asia’s Conflict Is Testing the Hidden Fragility of Pharma Trade
-
India’s Latest Manufacturing Clarification Is Really a Delayed Regulatory Line in the Sand
-
Global Ag M&A in 2025 Looked Less Like Expansion and More Like Selection
-
South Korea Tests Arctic Commercial Route as Asian Exporters Seek New Logistics Alternatives
-
Affordable GLP-1s Could Rewrite the Global Obesity Market
-
South Africa Wants Lenacapavir at Home, Not Just Imported
Recommend Reading
-
Global Chemical Exports Are Freezing in 2026
-
Kraton Announces Strategic Plan to Streamline Polymer Operations in Berre, France
-
Hormuz Closes, Paint Feels It First: How a Barrel of Oil Rewrites the Cost of Every Barrel of Coatings
-
China Suspends Sulfuric Acid Exports, Global Copper and Fertilizer Supply Under Strain
-
Korea’s First Petrochemical Restructuring Approved, LDPE Market Concentration Surges to 82%
-
Shengyi Society’s Market Outlook for Caustic Soda on August 25, 2026: Volatile and Consolidating
-
Cost support weakens, PTA prices fluctuate downward
-
Business Society’s Market Outlook for Gasoline on August 25, 2026: Relatively Strong Consolidation
-
Cost support weakens, polyester staple fiber prices slightly decline
-
Business Society’s View on Soda Ash Market Trends on August 24, 2026: Stable Consolidation